Patents by Inventor Deborah Russell

Deborah Russell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8486381
    Abstract: The present invention relates to methods for treating intestinal fluid balance disorders and modulating intestinal fluid secretion and absorption using calcimimetics and calcilytics.
    Type: Grant
    Filed: August 28, 2006
    Date of Patent: July 16, 2013
    Assignee: Amgen Inc.
    Inventors: John Peter Geibel, Steven Charles Hebert, David Martin, Deborah A. Russell
  • Patent number: 8093299
    Abstract: The present invention relates to methods for treating bowel disorders using calcimimetics.
    Type: Grant
    Filed: March 31, 2008
    Date of Patent: January 10, 2012
    Assignees: Amgen Inc., Yale University
    Inventors: John Peter Geibel, Steven Charles Hebert, Patricia Hebert, legal representative, David Martin, Deborah A. Russell
  • Publication number: 20110131531
    Abstract: A dynamic touch interface in which users are able to flick or scroll within the dynamic touch interface such as a dock or carousel and view the contents of their applications and thus provides a touch friendly environment to a personal computer type operating system (i.e., a keyboard/mouse input type operating system). More specifically, the touch input environment implements dynamic icons such that the icons populate content which is viewed or experienced. For example, if a user launches a favorite band in a music application, the carousel is automatically populated with album art or a picture of the band. The next time the user visits the desktop, the music icon is replaced by an image of the band or artist. Also, in certain embodiments, the icon includes a brief description of the content (i.e., number of songs or albums in folder).
    Type: Application
    Filed: December 2, 2009
    Publication date: June 2, 2011
    Inventors: Deborah Russell, Angela Blair, Keith Kozak
  • Publication number: 20090018135
    Abstract: The present invention relates to methods for treating or preventing bowel disorders using calcimimetics.
    Type: Application
    Filed: March 31, 2008
    Publication date: January 15, 2009
    Applicants: Amgen Inc., John Peter GEIBEL, Steven Charles HEBERT
    Inventors: John Peter Geibel, Steven Charles Hebert, Patricia Hebert, David Martin, Deborah A. Russell
  • Publication number: 20070060625
    Abstract: The present invention relates to methods for treating or preventing intestinal fluid balance disorders and modulating intestinal fluid secretion and absorption using calcimimetics and calcilytics.
    Type: Application
    Filed: August 28, 2006
    Publication date: March 15, 2007
    Applicants: Amgen Inc., John Peter Geibel, Steven Charles Hebert
    Inventors: John Geibel, Steven Hebert, David Martin, Deborah Russell
  • Patent number: 6599879
    Abstract: The present invention relates to the administration of Keratinocyte Growth Factor-2 (KGF-2) to stimulate proliferation of platelets and to increase levels of fibrinogen, albumin, globulin and total serum protein. Further, the present invention relates to administering KGF-2 to protect or treat the bladder and prostate. Moreover, the present invention relates to administering KGF-2 to stimulate growth of nasal, oral, and esophageal mucosa, lacrimal glands, salivary glands and Goblet cells.
    Type: Grant
    Filed: February 12, 1999
    Date of Patent: July 29, 2003
    Assignee: Human Genome Sciences, Inc.
    Inventors: Pablo Jimenez, Mark A. Rampy, Donna Mendrick, Deborah Russell, Arthur Louie
  • Patent number: 5733871
    Abstract: Intravenous administration and pharmaceutically acceptable compositions of neurotrophic factors for treating neuronal damage in the central nervous system of individuals in need of such treatment are disclosed. The neuronal damage associated with ischemia, hypoxia, or neurodegeneration may result from stroke or cardiac arrest. This invention provides for the intravenous administration of neurotrophic factors such as bFGF, aFGF, NGF, CNTF, BDNF, NT3, NT4, IGF-I and IGF-II.
    Type: Grant
    Filed: March 16, 1995
    Date of Patent: March 31, 1998
    Assignee: The General Hospital Corporation
    Inventors: Brian J. Alps, Christine Mary Brown, Franklin D. Collins, Caroline J. Emmett, Michael Spedding, Deborah Russell, Seth P. Finklestein, Michael A. Moskowitz, Roger Lewis Whiting
  • Patent number: 5691313
    Abstract: The present invention provides methods for treating impotency with the use of a therapeutically effective amount of ciliary neurotrophic factor (CNTF). Pharmaceutical compositions containing CNTF in a pharmaceutically acceptable carrier are also provided.
    Type: Grant
    Filed: August 26, 1996
    Date of Patent: November 25, 1997
    Assignee: Amgen Inc.
    Inventor: Deborah A. Russell